COVID-19 and CKD: Employment, Food Security and Healthcare in El Salvador
Authors:
- Jessica H. LeiblerJLJessica H. Leibler
- Sinead A. KeoghSKSinead A. Keogh
- Emmanuel JarquínEJEmmanuel Jarquín
- Ramon Garcia-TrabaninoRGRamon Garcia-Trabanino
- Juan José Amador VelázquezJVJuan José Amador Velázquez
- Damaris Lopez PilarteDPDamaris Lopez Pilarte
- Marvin BeltranMBMarvin Beltran
- Iris S. DelgadoIDIris S. Delgado
- Zoe E. PetropoulosZPZoe E. Petropoulos
- David J. FriedmanDFDavid J. Friedman
- Daniel R. BrooksDBDaniel R. Brooks
- Madeleine K. ScammellMSMadeleine K. Scammell
Open Access
- 9 November 2022
- journal article
- research article
- Published by Ubiquity Press, Ltd. in Annals of Global Health
- Vol. 88 (1) , 101
Abstract
In Central America, the COVID-19 pandemic coexists with a devastating epidemic of chronic kidney disease of unknown origin. The consequences of these overlapping health crises remain largely unknown. We assessed vulnerability to and impact of the first wave of COVID-19 on participants in a cohort study of chronic kidney disease (CKD) in El Salvador (n = 229). Participants were contacted by phone during August and September 2020. We queried changes to employment, healthcare access, household income and food security due to the pandemic (from March 2020 until the time of the interview) and COVID-19-associated symptoms during that time. We reached 94% of the cohort (n = 215). Nearly 40% of participants reported an unexpected change in employment or work activities and 8.8% reported new unemployment due to the pandemic. Participants with CKD (n = 27) had higher odds of reporting new income insecurity, food insecurity, and reductions in medical care access due to the pandemic. COVID-19-associated symptoms (an approximation of disease) were reported in 7.0% (n = 15). Participants with CKD were more likely to report COVID-19-associated symptoms compared to those without CKD, although these differences were not statistically significant. Overall, participants with CKD suffered greater economic consequences as a result of the pandemic and may have experienced higher incidence of COVID-19 disease, although laboratory diagnostics would be required to draw this conclusion. Longitudinal analyses are required to comprehensively evaluate the implications of the pandemic for individuals with CKD in Central America.Keywords
This publication has 24 references indexed in Scilit:
- COVID-19 and dengue, co-epidemics in Ecuador and other countries in Latin America: Pushing strained health care systems over the edgeTravel Medicine and Infectious Disease, 2020
- COVID‐19 and maternal and child food and nutrition insecurity: a complex syndemicMaternal & Child Nutrition, 2020
- Objective olfactory evaluation of self‐reported loss of smell in a case series of 86 COVID‐19 patientsHead & Neck, 2020
- COVID-19 in Latin AmericaThe Lancet Infectious Diseases, 2020
- Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)International Journal of Infectious Diseases, 2020
- Trust, Conflict, and Engagement in Occupational Health: North American Epidemiologists Conduct Occupational Study in Communities Affected by Chronic Kidney Disease of Unknown Origin (CKDu)Current Environmental Health Reports, 2019
- Clinical Evidence of Acute Mesoamerican NephropathyThe American Journal of Tropical Medicine and Hygiene, 2017
- Heat stress, dehydration, and kidney function in sugarcane cutters in El Salvador – A cross-shift study of workers at risk of Mesoamerican nephropathyEnvironmental Research, 2015
- The Central American Epidemic of CKDClinical Journal of the American Society of Nephrology, 2013
- The Neglected Tropical Diseases of Latin America and the Caribbean: A Review of Disease Burden and Distribution and a Roadmap for Control and EliminationPLOS Neglected Tropical Diseases, 2008